Cristiano Magnaghi
Overview
Explore the profile of Cristiano Magnaghi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brioni E, Guerriero M, Magnaghi C, Pozzi D, Finazzi M, Giulia Bruna D, et al.
G Ital Nefrol
. 2025 Mar;
42(1).
PMID: 40026229
Moral Distress in the nursing profession represents an increasingly important issue. Patients undergoing dialysis treatment have a long and complex clinical path and the nurse is required to express clinical...
2.
Damanti S, De Lorenzo R, Citterio L, Zagato L, Brioni E, Magnaghi C, et al.
Front Med (Lausanne)
. 2025 Jan;
11():1465066.
PMID: 39845826
Background: Frailty, a geriatric syndrome associated with adverse outcomes, lacks a universal definition. No consensus exists on the most effective frailty scale for predicting mortality. Methods: This prospective observational study...
3.
Damanti S, Citterio L, Zagato L, Brioni E, Magnaghi C, Simonini M, et al.
Front Endocrinol (Lausanne)
. 2024 Oct;
15:1412160.
PMID: 39464190
Background: Obesity and frailty are prevalent geriatric conditions that share some pathophysiological mechanisms and are associated with adverse clinical outcomes. The relationship between frailty, obesity, and polymorphism remains inadequately explored....
4.
Damanti S, Citterio L, Zagato L, Brioni E, Magnaghi C, Simonini M, et al.
BMC Geriatr
. 2024 Jul;
24(1):638.
PMID: 39085777
Background: The ageing process is characterized by a change of body composition with an increase of fat mass and a reduction of muscle mass. Above a certain threshold these alterations...
5.
Merolla A, De Lorenzo R, Paolazzi G, Critelli S, Palladini M, Damanti S, et al.
Int Clin Psychopharmacol
. 2024 Feb;
39(6):361-368.
PMID: 38381905
Coronavirus disease 2019 (COVID-19) may lead to neuropsychiatric sequelae. Palmitoylethanolamide (PEA) is an anti-inflammatory and neuroprotective amide used in depressive syndromes. Here we investigate whether micronized/ultramicronized (m/um) PEA improves neuropsychiatric...
6.
Brioni E, Villa G, Manara D, Farinone S, Magnaghi C, Scuratti D, et al.
G Ital Nefrol
. 2023 Nov;
40(5).
PMID: 38010252
Polycystic kidney disease (ADPKD) is the most common monogenic cause of End Stage Renal Disease (ESRD), and, thus, of kidney transplantation and dialysis. Educational interventions aimed to improve adherence to...
7.
Damanti S, Cilla M, Cilona M, Fici A, Merolla A, Pacioni G, et al.
Front Med (Lausanne)
. 2022 Aug;
9:834887.
PMID: 35911387
Background: A motley postacute symptomatology may develop after COVID-19, irrespective of the acute disease severity, age, and comorbidities. Frail individuals have reduced physiological reserves and manifested a worse COVID-19 course,...
8.
Brioni E, Magnaghi C, Villa G, Giannetta N, Manara D, Magni G, et al.
G Ital Nefrol
. 2022 Jul;
39(3).
PMID: 35819041
Chronic renal failure is an epidemic in elderly patients. Older population have an increased prevalence of frailty and sarcopenia, associated with a wide range of adverse health outcomes such as...
9.
De Lorenzo R, Palmisano A, Esposito A, Gnasso C, Nicoletti V, Leone R, et al.
Front Nutr
. 2022 Apr;
9:846901.
PMID: 35464004
Background: Persistent symptoms including dyspnea and functional impairment are common in COVID-19 survivors. Poor muscle quality (myosteatosis) associates with poor short-term outcomes in COVID-19 patients. The aim of this observational...
10.
De Lorenzo R, Magnaghi C, Cinel E, Vitali G, Martinenghi S, Mazza M, et al.
Front Med (Lausanne)
. 2022 Mar;
9:781410.
PMID: 35280880
Objective: To assess the prevalence of respiratory sequelae of Coronavirus disease 2019 (COVID-19) survivors at 6 months after hospital discharge and develop a model to identify at-risk patients. Patients And...